Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05694338 · ClinicalTrials.gov registry record

Frailty in Patients With Gastrointestinal Cancer Who Are Undergoing Major Surgery

A clinical trial of Gastrointestinal Cancer, sponsored by The Guthrie Clinic.

Active
Registry status
100
Enrollment target
2
Study locations

NCT05694338 is a study of Gastrointestinal Cancer that is active but no longer recruiting, run by The Guthrie Clinic. The registered enrollment target is 100 participants, below the 232-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target (57% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05694338, a study of Gastrointestinal Cancer, is active but no longer recruiting, sponsored by The Guthrie Clinic.

ACTIVE NOT RECRUITING
Registry status
100 participants
Enrollment target
2
Study locations

Study Summary

This research is for patients who have gastrointestinal cancer and have a planned major surgery. The purpose of this research is to identify cancer patients who may be at risk for frailty. Frailty is common in older adults and may include symptoms of weight loss, weakness, fatigue, low activity, slow walking and other illnesses. Frailty may increase the risk of problems after major surgery. The study will involve a survey, a blood sample, and a review of medical records.

Conditions Studied

Interventions

  • OTHER Frailty survey

Study Locations (2)

New York

  • Guthrie Medical Group - East Corning

Pennsylvania

  • Robert Packer Hospital - Sayre

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-03-13
Est. Completion 2027-06-01

Sponsor

The Guthrie Clinic

17 total trials

What the Registry Record Tells You About NCT05694338

The ClinicalTrials.gov registry entry for NCT05694338 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 232-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target (57% lower). The listed sponsor is The Guthrie Clinic, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastrointestinal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Frailty survey is the first listed.

NCT05694338 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05694338 about?

NCT05694338 is a clinical study titled "Frailty in Patients With Gastrointestinal Cancer Who Are Undergoing Major Surgery". This research is for patients who have gastrointestinal cancer and have a planned major surgery. The purpose of this research is to identify cancer patients who may be at risk for frailty. Frailty is common in older adults and may include symptoms of weight loss, weakness, fatigue, low activity, slo...

What is the current status of trial NCT05694338?

This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2023-03-13. Estimated completion is 2027-06-01.

What conditions does trial NCT05694338 study?

This clinical trial studies the following conditions: Gastrointestinal Cancer.

What interventions are being tested in trial NCT05694338?

The interventions under investigation include: Frailty survey (OTHER).

Who is sponsoring clinical trial NCT05694338?

This trial is sponsored by The Guthrie Clinic, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05694338 being conducted?

This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastrointestinal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.